Visit our USA website
Re:Cognition Health has announced the launch of CognitionCheck, an innovative new cognitive health assessment designed to help identify early signs of Alzheimer’s disease and other causes of cognitive decline.
As understanding of Alzheimer’s disease continues to advance, so too do the tools available to assess brain health. CognitionCheck brings together some of the latest developments in cognitive assessment, neuroimaging and biomarker science within a single, streamlined clinical pathway, helping individuals gain a clearer understanding of their cognitive health.
Introducing CognitionCheck: A Comprehensive Assessment of Brain Health
CognitionCheck is a comprehensive assessment available to adults aged 50 and over. It combines advanced cognitive testing, MRI brain imaging, blood biomarker analysis and specialist clinical review to provide a detailed evaluation of brain health.
Developed by Re:Cognition Health’s team of cognitive health specialists, CognitionCheck reflects the growing shift towards earlier and more accurate detection of Alzheimer’s disease and other neurodegenerative conditions.
A New Approach to Cognitive Health Assessment
While cognitive testing, MRI scans and blood biomarker analysis are available individually in some healthcare settings, CognitionCheck is one of the first assessments in the UK to combine AI-powered cognitive testing, MRI brain imaging, p-Tau217 blood biomarker analysis and specialist physician consultation within a single, integrated clinical pathway.
The assessment includes:
- AI-powered cognitive testing designed to detect subtle changes in memory, thinking and cognitive performance
- MRI brain imaging to identify structural changes within the brain
- p-Tau217 blood biomarker testing, one of the most promising emerging indicators associated with Alzheimer’s disease pathology
- Review and interpretation by specialist cognitive health physicians
- A single patient journey that combines multiple diagnostic technologies into one comprehensive assessment
By bringing these elements together, CognitionCheck moves beyond traditional symptom-based assessments and provides a more complete picture of an individual’s cognitive health.
Why CognitionCheck Is Setting a New Standard in Alzheimer’s Diagnostics
CognitionCheck is one of the first assessments in the UK to combine AI-driven cognitive testing, MRI brain imaging, p-Tau217 blood biomarker analysis and specialist physician consultation within a single patient pathway.
Globally, healthcare systems are increasingly moving towards biomarker-led diagnosis of Alzheimer’s disease. While individual components of CognitionCheck are available in various clinical settings around the world, the combination of these technologies and specialist expertise within one accessible assessment pathway remains highly innovative.
This integrated approach reflects the future direction of Alzheimer’s diagnostics, where biomarkers, imaging and cognitive assessment work together to support earlier and more accurate identification of individuals who may be at risk.
The Science Driving Earlier and More Accurate Diagnosis
Although CognitionCheck itself is a newly launched clinical assessment pathway, the individual technologies used within the service are supported by extensive international research and clinical validation.
MRI brain imaging has long been recognised as an important component of dementia assessment, helping clinicians identify changes in brain structure. Cognitive testing remains a key tool for evaluating memory, attention and other thinking skills.
One of the most significant advances in recent years has been the development of blood biomarkers associated with Alzheimer’s disease. Among these, p-Tau217 has emerged as one of the most promising indicators of Alzheimer’s-related pathology, demonstrating strong accuracy in identifying biological changes associated with the disease.
By combining cognitive assessment, imaging and biomarker analysis, Re Health can provide a more comprehensive understanding of brain health than would be possible through any single test alone.
Who Should Consider CognitionCheck?
CognitionCheck is available to adults aged 50 and over. Many individuals seek assessment because they have noticed changes in memory, concentration or thinking abilities. Others may have a family history of dementia and want to better understand their future risk profile.
The service may also appeal to those taking a proactive approach to healthy ageing and looking to gain valuable insight into their long-term cognitive wellbeing.
Advanced Cognitive Assessment, Available Nationwide
Although launched from the internationally renowned Harley Street Health District, CognitionCheck has been designed to be accessible nationwide.
Through Re:Cognition Health’s partnership with Scan.com, patients can access MRI imaging through a network of more than 300 imaging centres across the UK, making advanced cognitive assessment more convenient regardless of location.
Patients can access CognitionCheck directly by contacting Re:Cognition Health and speaking with the clinical team. In addition, Re:Cognition Health maintains longstanding relationships with healthcare professionals across neurology, psychiatry, geriatrics and primary care who may recommend comprehensive cognitive assessment for suitable patients.
Shaping the Future of Brain Health Screening
As disease-modifying treatments for Alzheimer’s disease become more widely available, the importance of early and accurate diagnosis will continue to grow.
Healthcare systems around the world are exploring how blood biomarkers, advanced imaging and cognitive testing can be incorporated into future dementia pathways. While CognitionCheck is currently available as a private assessment, Re:Cognition Health welcomes wider adoption of innovative approaches that enable earlier diagnosis and intervention.
Looking ahead, Re:Cognition Health plans to continue refining CognitionCheck as new diagnostic technologies and biomarkers become available, ensuring patients have access to the latest advances in cognitive health assessment.
The long-term vision is to help establish proactive cognitive health screening as a routine part of healthy ageing, much like cardiovascular risk assessments are used today.
Take the Next Step Towards Understanding Your Brain Health
Whether you have noticed changes in memory, have a family history of dementia or simply want to take a proactive approach to your cognitive health, CognitionCheck can provide valuable insight.
To learn more about CognitionCheck or speak with a member of the clinical team, visit www.recognitionhealth.com or contact Re:Cognition Health directly.
